Kevin Hrusovsky has dedicated his 30-year career to leading disruptive medical technology companies and shepherding a global movement to transform healthcare to Precision Health. He created Powering Precision Health foundation, an internationally renowned non-profit promoting a new era of medicine using biomarker innovation to achieve precision medicine. Kevin has always been committed to accelerating adoption and value creation for many “game changing” non-invasive early detection technologies for Oncology, Neurodegeneration and Cardiology which are transforming drug development and disease prevention. Before Quanterix, he was CEO of Caliper Life Sciences, and Zymark Corporation, as well as, President of Life Sciences at PerkinElmer. He is the recipient of several distinguished awards including the 2019 EY Entrepreneur of the Year®, the 2018 Lifetime Achievement Award for Leadership and the E.G. Bailey Entrepreneurship Award (2013), both from The Ohio State University.
Healthcare diagnostics is at the core of clinical decision making. Early diagnosis can increase the chances of a positive outcome, helping to improve the lives of patients and save payers the costs of further treatment. As health systems move from treatment to prevention, and from volume to value, diagnostics can accelerate this shift. Investment in innovative lab services and technologies is critical in enabling hospitals and healthcare systems to improve efficiencies in the lab, optimize their laboratories to realize gains, and deliver on the imperatives of improving patient outcomes while reducing costs. This session will provide insights from payers that have been actively investing in companies developing innovative lab services and technologies.